Charles River Laboratories International Inc. (NYSE: CRL) is -18.40% lower on its value in year-to-date trading and has touched a low of $161.65 and a high of $275.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CRL stock was last observed hovering at around $200.62 in the last trading session, with the day’s loss setting it -7.72%.
Currently trading at $192.90, the stock is -2.60% and -7.77% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.04 million and changing -3.85% at the moment leaves the stock -14.23% off its SMA200. CRL registered -2.36% loss for a year compared to 6-month loss of -27.33%. The firm has a 50-day simple moving average (SMA 50) of $208.4696 and a 200-day simple moving average (SMA200) of $224.8421.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -5.72% gain in the last 1 month and extending the period to 3 months gives it a -6.68%, and is -6.40% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.88% over the week and 2.76% over the month.
Charles River Laboratories International Inc. (CRL) has around 21800 employees, a market worth around $9.96B and $4.08B in sales. Current P/E ratio is 22.80 and Fwd P/E is 17.89. Profit margin for the company is 10.73%. Distance from 52-week low is 19.33% and -29.85% from its 52-week high. The company has generated returns on investments over the last 12 months (6.67%).
The EPS is expected to shrink by -6.15% this year
948.0 institutions hold shares in Charles River Laboratories International Inc. (CRL), with institutional investors hold 104.35% of the company’s shares. The shares outstanding are 51.34M, and float is at 51.04M with Short Float at 3.70%. Institutions hold 103.37% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 6.1 million shares valued at $1.26 billion. The investor’s holdings represent 11.8396 of the CRL Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.09 million shares valued at $1.05 billion to account for 9.8699 of the shares outstanding. The other top investors are STATE STREET CORP which holds 2.09 million shares representing 4.052 and valued at over $431.52 million, while KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds 3.7031 of the shares totaling 1.91 million with a market value of $394.36 million.
Charles River Laboratories International Inc. (CRL) Insider Activity
The most recent transaction is an insider sale by LaPlume Joseph W, the company’s EVP, Corp Strategy & Develop. SEC filings show that LaPlume Joseph W sold 1,780 shares of the company’s common stock on Aug 08 ’24 at a price of $199.36 per share for a total of $0.35 million. Following the sale, the insider now owns 22521.0 shares.
Still, SEC filings show that on Aug 01 ’24, FOSTER JAMES C (Chairman, President and CEO) disposed off 25,000 shares at an average price of $250.00 for $6.25 million. The insider now directly holds 188,251 shares of Charles River Laboratories International Inc. (CRL).
